TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
6.89
+0.25 (3.77%)
Dec 31, 2025, 11:42 AM EST - Market open
TriSalus Life Sciences Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$11.50
Upside
+66.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +74.17% | Dec 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +59.65% | Mar 28, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +59.65% | Jan 24, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +45.14% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +59.65% | Nov 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +59.65% | Nov 11, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $13 | Buy | Initiates | $13 | +81.42% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +45.14% | Sep 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +74.17% | Jun 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +74.17% | May 30, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +132.22% | May 10, 2024 |